OVIT (OncoVista Innovative Therapies) Other Stockholders Equity: $0.00 Mil (As of Sep. 2015)


What is OncoVista Innovative Therapies Other Stockholders Equity?

OncoVista Innovative Therapies OVIT Other Stockholders Equity is $0.00 Mil as of Sep. 2015.

OncoVista Innovative Therapies's Other Stockholders Equity for the quarter that ended in Sep. 2015 was $0.00 Mil.

OncoVista Innovative Therapies's quarterly Other Stockholders Equity increased from Mar. 2015 ($0.00 Mil) to Jun. 2015 ($0.00 Mil) but then declined from Jun. 2015 ($0.00 Mil) to Sep. 2015 ($0.00 Mil).

OncoVista Innovative Therapies's annual Other Stockholders Equity declined from Dec. 2012 ($0.00 Mil) to Dec. 2013 ($-0.00 Mil) but then increased from Dec. 2013 ($-0.00 Mil) to Dec. 2014 ($0.00 Mil).

OncoVista Innovative Therapies Other Stockholders Equity Historical Data

* Premium members only.

The historical data trend for OncoVista Innovative Therapies's Other Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

OncoVista Innovative Therapies Other Stockholders Equity Chart

OncoVista Innovative Therapies Annual Data
Trend Dec05 Dec06 Dec07 Dec08 Dec09 Dec10 Dec11 Dec12 Dec13 Dec14
Other Stockholders Equity
Get a 7-Day Free Trial Premium Member Only Premium Member Only -0.00 0.00 0.00 -0.00 0.00

OncoVista Innovative Therapies Quarterly Data
Dec10 Mar11 Jun11 Sep11 Dec11 Mar12 Jun12 Sep12 Dec12 Mar13 Jun13 Sep13 Dec13 Mar14 Jun14 Sep14 Dec14 Mar15 Jun15 Sep15
Other Stockholders Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

OncoVista Innovative Therapies Other Stockholders Equity Calculation

Other Stockholders Equity is instruments issued by the company that cannot be identified by other specific items in the Equity section. GuruFocus lists following items in "Total Stockholders Equity" section:
Common Stock
Preferred Stock
Retained Earnings
Accumulated other comprehensive income (loss)
Additional Paid-In Capital
Treasury Stock
Other Stockholders Equity

What does a Other Stockholders Equity of $0.00 Mil mean?
OncoVista Innovative Therapies (OVIT) has a Other Stockholders Equity of $0.00 Mil as of Sep. 2015. Other Equity is instruments issued by the company that cannot be identified by other specific items in the Equity section. View historical data on OncoVista Innovative Therapies and its competitors.
Is OncoVista Innovative Therapies' Other Stockholders Equity too high?
OncoVista Innovative Therapies' current Other Stockholders Equity is $0.00 Mil.
How does OncoVista Innovative Therapies' Other Stockholders Equity compare to RSPI and HSTC?
OncoVista Innovative Therapies' Other Stockholders Equity of $0.00 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Stockholders Equity for a Biotechnology company?
A good Other Stockholders Equity depends on the Biotechnology industry context. However, Other Stockholders Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Stockholders Equity mean?
A high Other Stockholders Equity can signal that a stock is expensive relative to its fundamentals. Other Equity is instruments issued by the company that cannot be identified by other specific items in the Equity section. View historical data on OncoVista Innovative Therapies and its competitors. OncoVista Innovative Therapies's current Other Stockholders Equity is $0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is OncoVista Innovative Therapies stock overvalued right now?
OncoVista Innovative Therapies (OVIT) has a current Other Stockholders Equity of $0.00 Mil. The current Other Stockholders Equity is $0.00 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Stockholders Equity calculated?
Other Stockholders Equity is calculated from a company's financial statements. For OncoVista Innovative Therapies (OVIT), the current Other Stockholders Equity is $0.00 Mil as of Sep. 2015. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

OncoVista Innovative Therapies Business Description

Address 14785 Omicron Drive, Suite 104, San Antonio, TX, USA, 78245
OncoVista Innovative Therapies Inc is a biopharmaceutical company. It is engaged in developing anticancer therapies by utilizing tumor-associated biomarkers.